Event

The Design and Analysis of N of 1 Trials

Radisson Blu Edwardian Heathrow Hotel <br>140 Bath Road, Hayes, Middlesex, UB3 5AW <br><br><b>Start:</b> 09:00 <br><b>Finish:</b> 17:00

PLEASE CLICK HERE TO REGISTER!

Introduction

N of 1 trials are trials in which individual patients are repeatedly treated with experimental and control treatments in a deliberate and designed manner using principles of control, randomisation and replication. Their uses include personalising treatment and increasing efficiency by reducing the number of patients it is necessary to study.

In chronic diseases, sets of n-of-1 trials (in which a limited number of patients follow an n-of-1 protocol) have great potential as phase IV trials for understanding components of variation but may also constitute possible Phase III programmes for rare diseases. They can also be used as phase II studies for proof of concept and dose-finding. However, they are often poorly analysed and, indeed, much of the published advice is poor.

This course will present the latest thinking on n-of-1 trials and cover not only their analysis through SAS®, R® GenStat® and meta-analysis packages but also approaches to design. They will also be critically examined as to their potential use in a) establishing average effects of treatment b) studying the extent to which such effects vary from patient to patient and c) optimising treatment for individual patients.

Course leader

This course will be given by Professor Stephen Senn, of the Luxembourg Institute of Health, who is well- known for his work on the design and analysis of clinical trials and the application of statistics in drug development. 

Topics covered

  • Uses of n-of-1 trials and purposes of analysis
    • Showing the treatment can work
    • Understanding variation in effect
    • Predicting effects
  • Design 
    • Randomisation in cycles
    • Randomisation in patient blocks
  • Graphical presentation of results
    • Trellis plots
    • Dot plots
  • Causal analysis
  • Analysis of variance
    • Block structure and the Wilkinson & Roger notation
    • Main effect models
    • Allowing for interaction
  • Summary measures approaches
  • Mixed models
    • Estimation
    • Best linear unbiased predictors (shrunk estimates)
  • Meta-analysis approaches
    • Fixed effects
    • Random effects
  • Binary data
  • Planning issues

 

Early
(up to and including 6th June)

Late
(after 6th June)

Academic (includes non voting reduced membership)

£245 + VAT

£295 + VAT

PSI member

£295 + VAT

£345 + VAT

Non-member (includes PSI membership for one year)

£375 +VAT

£425 + VAT


Registration closes 28th June 2016

PLEASE CLICK HERE TO REGISTER!

Upcoming Events

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Book Club - The Art of Explanation: How to Communicate with Clarity and Confidence

Develop your non-technical skills by reading The Art of Explanation by Ros Atkins and joining the Sept-Dec 2025 book club. You will be invited to join facilitated discussions of the concepts and ideas and apply skills from the book in-between sessions.

PSI Journal Club: Randomization

Date: Tuesday 9th September 2025 Join us to hear Sofia Weigle and Weng-Kee Wong present their recent work.

PSI Training Course: Pediatric Extrapolation

This course is aimed at biostatisticians with no or some pediatric drug development experience who are interested to further their understanding. We will give you an introduction to the pediatric drug development landscape. This will include identifying the key regulations and processes governing pediatric development, a discussion on the needs and challenges when conducting pediatric research and a focus on the ways to overcome these challenges from a statistical perspective.

PSI Career Young Virtual Event (Q3 2025)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Latest Jobs

Associate Director Biostatistics in Early Development - Novartis

As an Associate Director Biostatistics Early Development, you will be a key member of our biostatistics group, you will play a crucial role in the design, analysis, and interpretation of clinical trials for early development programs.

Associate Director Biostatistics, Real World Data - Novartis

If you are passionate about biostatistics and real-world data, and are looking for an exciting opportunity to contribute to groundbreaking research, we encourage you to apply.

Associate Director, Pharmacometrics - Novartis

Are you passionate about making a difference in the world of healthcare? Novartis is seeking a dynamic and experienced professional to join our team in London at The Westworks.

Director of HTA Biostatistics & Medical Affairs - Novartis

As the Director of HTA Biostatistics & Medical Affairs, you will play a pivotal role in shaping the future of healthcare by providing strategic biostatistical leadership and expertise.

Senior Principal Biostatistician - Novartis

As a Senior Principal Biostatistician, you will be responsible and accountable for all statistical work, both scientific and operational, for one or more assigned clinical trials